ArticleJournal of family medicine and primary care2025
Clinico immunological profile of immune-mediated disorders in South Indian children- A prospective observational study.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Immune-mediated diseases can affect any part of the body of genetically susceptible individuals. Few diseases predominantly affect a single organ, while others present with multisystemic manifestations. Methods: We collected data on the clinical, demographic, and immunological details of children with immune-mediated diseases presenting over a period of three years from January 2020 to December 2022 retrospectively from the children enrolled in Pediatric immunology clinic of a tertiary care hospital in South India. Results: The prevalence of immune-mediated diseases among children visiting the hospital for various illnesses was 5 per 1000 children, and the percentage of positive autoantibodies in children with connective tissue disorders and single-organ autoimmune disorders was 41.3% and 40.7%, respectively. The most common connective tissue disorder in our study was juvenile idiopathic arthritis (21 patients), among which 9 / 21 (42.8%) were autoantibody positive. ANA was the most common antibody in both groups (47.5%). Only 3.4% had rheumatoid factor positivity in the connective tissue group. The most common single-organ autoimmune disorders in children are autoimmune thyroid disorders (25), followed by autoimmune hematological disorders (18), while autoantibodies were more common in patients with thyroid disorders (18 / 25) and autoimmune hepatitis (7 / 8). Conclusion: Early clinical suspicion and prompt diagnosis in children with prolonged illness or atypical presentation is essential to ensure remission and prevent complications, morbidity and mortality. Further research is needed to identify early biomarkers in immune-mediated pediatric disorders that will help to confirm the diagnosis and guide physicians to start immunosuppressive therapy at the right time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.